Can pregnant women safely receive MAT?

Pregnant women can safely receive Medication-Assisted Treatment (MAT) with appropriate medical supervision, making this option the correct choice. MAT, which often includes the use of medications like methadone or buprenorphine, has been shown to be effective in treating opioid use disorder even during pregnancy. It is essential, however, for these women to be closely monitored by healthcare providers to manage potential risks and to ensure the health and safety of both the mother and the developing fetus.

Medications used in MAT can mitigate withdrawal symptoms, reduce the risk of relapse, and ultimately improve outcomes for both mother and child when done under proper medical guidance. This management typically involves a comprehensive care approach, including behavioral therapy and psychosocial support, tailored to the individual needs of the patient.

Other options suggest limitations or prohibitions that do not reflect current clinical guidelines and research regarding MAT and pregnancy. Understanding the role of medical supervision and individualized treatment plans is critical in ensuring the best outcomes in these situations.